secwatch / observer
8-K filed June 9, 2025, 7:59 PM ET ticker GNPX CIK 0001595248
regulatory confidence high sentiment neutral materiality 0.60

Genprex, Inc. (GNPX): Nasdaq/NYSE listing notice — Genprex regains Nasdaq stockholders' equity compliance; bid price issue unresolved

Genprex, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Genprex, Inc. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1), 5550(b)(2), 5550(b)(3)).

Exchange
nasdaq
Notice
compliance regained
Deficiency
stockholders equity
Rules
5550(b)(1), 5550(b)(2), 5550(b)(3)
Exact text from the filing
June 6, 2025, Genprex, Inc. (the “Company”) received a letter (the “June 2025 Compliance Letter”) from the Listing Qualifications Department (the “Nasdaq Staff”) of The Nasdaq Stock Market (“Nasdaq”) providing written confirmation that the Company has regained compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”). The June 2025 Compliance Letter was pursuant to a previous letter received on November 19, 2024 (the “November 2024 Notice”) from the Nasd
View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Genprex, Inc. filing history →

Source: SEC EDGAR
accession 0001437749-25-019767
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.